FAQ

Model for end-stage liver disease score

Known as: MELD - Score, MELD01-Score, MELD0101 
Model for End Stage Liver Disease (MELD) MELD score.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
012320052016

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Related mentions per year

Related mentions per year

1995-2018
1990200020102020
Model for end-stage liver disease score
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
BACKGROUND Early allograft dysfunction after liver transplantation (LTX) is not well defined. The aim of this study was to… (More)
Is this relevant?
2014
2014
Comparison of 3 scoring systems to predict mortality from unstable upper gastrointestinal bleeding in cirrhotic patients.
OBJECTIVE We aimed to compare the performance of Glasgow-Blatchford, preendoscopic Rockall, and model for end-stage liver disease… (More)
Is this relevant?
2014
2014
Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.
BACKGROUND AND AIMS The Maddrey Discriminant Function (mDF) score and the Model for End-Stage Liver Disease (MELD) score are… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2011
2011
Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy.
BACKGROUND & AIMS Pregnancy is rare among patients with cirrhosis, and data about complications and outcomes are sparse. We… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score.
Although atazanavir is widely used in hepatitis C virus (HCV)-HIV-1 patients, little is known about its safety in advanced liver… (More)
  • figure 1
  • table 1
Is this relevant?
2010
2010
Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality.
BACKGROUND The Model for End-Stage Liver Disease (MELD) predicts events in cirrhotic subjects undergoing major surgery and may… (More)
  • table 1
  • figure 1
  • table 3
  • table 2
  • figure 2
Is this relevant?
2007
2007
Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
BACKGROUND The models for end-stage liver disease (MELD) and serum sodium (SNa) are important prognostic markers in cirrhosis. A… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.
UNLABELLED Although it is often functional at presentation, acute renal failure has a poor prognosis in patients with cirrhosis… (More)
Is this relevant?
2006
2006
Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
BACKGROUND Prioritizing the liver transplant waiting list (WL) is subject to great variability. We present the experience of four… (More)
Is this relevant?
Review
2005
Review
2005
The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
HYPOTHESIS We hypothesized that the model for end-stage liver disease (MELD) score may be a better and less subjective method… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?